These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 21907241
1. Avian glycan-specific IgM monoclonal antibodies for the detection and quantitation of type A and B haemagglutinins in egg-derived influenza vaccines. Legastelois I, Chevalier M, Bernard MC, de Montfort A, Fouque M, Pilloud A, Serraille C, Devard N, Engel O, Sodoyer R, Moste C. J Virol Methods; 2011 Dec; 178(1-2):129-36. PubMed ID: 21907241 [Abstract] [Full Text] [Related]
2. An ELISA-based assay for determining haemagglutinin potency in egg, cell, or recombinant protein derived influenza vaccines. Bodle J, Vandenberg K, Laurie K, Barr IG, Zhang Y, Rockman S. Front Immunol; 2023 Dec; 14():1147028. PubMed ID: 37033922 [Abstract] [Full Text] [Related]
3. Determination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodies. Verma S, Soto J, Vasudevan A, Schmeisser F, Alvarado-Facundo E, Wang W, Weiss CD, Weir JP. PLoS One; 2017 Dec; 12(4):e0175733. PubMed ID: 28423025 [Abstract] [Full Text] [Related]
4. An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination. Schmeisser F, Vodeiko GM, Lugovtsev VY, Stout RR, Weir JP. Vaccine; 2010 Mar 11; 28(12):2442-9. PubMed ID: 20074687 [Abstract] [Full Text] [Related]
5. Development and characterization of neutralizing monoclonal antibodies against the pandemic H1N1 virus (2009). Cabral TM, Berhane Y, Schmidt L, Tracz DM, Hole K, Leith M, Corbett CR. J Virol Methods; 2012 Jul 11; 183(1):25-33. PubMed ID: 22575685 [Abstract] [Full Text] [Related]
6. Development of an enzyme-linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion. Bodle J, Verity EE, Ong C, Vandenberg K, Shaw R, Barr IG, Rockman S. Influenza Other Respir Viruses; 2013 Mar 11; 7(2):191-200. PubMed ID: 22583601 [Abstract] [Full Text] [Related]
8. Newly established monoclonal antibodies for immunological detection of H5N1 influenza virus. Ohnishi K, Takahashi Y, Kono N, Nakajima N, Mizukoshi F, Misawa S, Yamamoto T, Mitsuki YY, Fu S, Hirayama N, Ohshima M, Ato M, Kageyama T, Odagiri T, Tashiro M, Kobayashi K, Itamura S, Tsunetsugu-Yokota Y. Jpn J Infect Dis; 2012 Mar 07; 65(1):19-27. PubMed ID: 22274153 [Abstract] [Full Text] [Related]
9. Simultaneous quantification of the viral antigens hemagglutinin and neuraminidase in influenza vaccines by LC-MSE. Creskey MC, Li C, Wang J, Girard M, Lorbetskie B, Gravel C, Farnsworth A, Li X, Smith DG, Cyr TD. Vaccine; 2012 Jul 06; 30(32):4762-70. PubMed ID: 22643214 [Abstract] [Full Text] [Related]
11. Plant-expressed HA as a seasonal influenza vaccine candidate. Shoji Y, Chichester JA, Bi H, Musiychuk K, de la Rosa P, Goldschmidt L, Horsey A, Ugulava N, Palmer GA, Mett V, Yusibov V. Vaccine; 2008 Jun 02; 26(23):2930-4. PubMed ID: 18440103 [Abstract] [Full Text] [Related]
12. A monoclonal antibody-based immunoassay for measuring the potency of 2009 pandemic influenza H1N1 vaccines. Schmeisser F, Vasudevan A, Soto J, Kumar A, Williams O, Weir JP. Influenza Other Respir Viruses; 2014 Sep 02; 8(5):587-95. PubMed ID: 25087462 [Abstract] [Full Text] [Related]
13. Monoclonal antibodies to the haemagglutinin HA1 subunit of the pandemic influenza A/H1N1 2009 virus and potential application to serodiagnosis. Samuel D, Warrener L, Hoschler K. J Med Virol; 2011 Apr 02; 83(4):559-67. PubMed ID: 21328368 [Abstract] [Full Text] [Related]
14. Comparative immunogenicity of recombinant adenovirus-vectored vaccines expressing different forms of hemagglutinin (HA) proteins from the H5 serotype of influenza A viruses in mice. Hu X, Meng W, Dong Z, Pan W, Sun C, Chen L. Virus Res; 2011 Jan 02; 155(1):156-62. PubMed ID: 20883733 [Abstract] [Full Text] [Related]
15. Haemagglutinin quantification and identification of influenza A&B strains propagated in PER.C6 cells: a novel RP-HPLC method. Kapteyn JC, Saidi MD, Dijkstra R, Kars C, Tjon JC, Weverling GJ, de Vocht ML, Kompier R, van Montfort BA, Guichoux JY, Goudsmit J, Lagerwerf FM. Vaccine; 2006 Apr 12; 24(16):3137-44. PubMed ID: 16490287 [Abstract] [Full Text] [Related]
19. Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e. Park KS, Seo YB, Lee JY, Im SJ, Seo SH, Song MS, Choi YK, Sung YC. Vaccine; 2011 Jul 26; 29(33):5481-7. PubMed ID: 21664216 [Abstract] [Full Text] [Related]